New drug cocktail aims to wipe out rectal cancer before surgery
NCT ID NCT05358704
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving a powerful mix of chemotherapy and radiation before surgery can completely eliminate rectal cancer in more patients. About 38 adults with rectal cancer will receive the experimental treatment and be followed for up to 4 years. The goal is to see if this approach is safe and leads to better outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER OF RECTUM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
RWJBarnabas Health - Community Medical Center
Toms River, New Jersey, 08755, United States
-
RWJBarnabas Health - Monmouth Medical Center
Lakewood, New Jersey, 08701, United States
-
RWJBarnabas Health - Robert Wood Johnson University Hospital, Somerset
Somerset, New Jersey, 08873, United States
-
RWJBarnabas Health - Saint Barnabas Medical Center, Livingston
Livingston, New Jersey, 07039, United States
-
Rutgers, The State University of New Jersey
New Brunswick, New Jersey, 08901, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can diet and vitamin c supercharge rectal cancer treatment?
- AI as a surgical Co-Pilot: predicting difficulty in rectal cancer
- A new radiation combo may spare the rectum in early cancer
- Can a triple-drug cocktail after short radiation eliminate rectal cancer without surgery?
- Metabolic MRI may reveal hidden cancer responses and spare patients from surgery
- Can a beetroot drink spot dangerous surgical leaks before they turn deadly?